2023 ´ëÇѽɺÎÀüÇÐȸ Ãß°è Çмú´ëȸ 1ÀÏÂ÷ : 2023-09-21
±³À°ÀÏÀÚ : 2023-09-21
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º ±×·£µåº¼·ë
±³À°ÁÖÁ¦ : 2023 ´ëÇѽɺÎÀüÇÐȸ Ãß°è Çмú´ëȸ 1ÀÏÂ÷
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ
´ã´çÀÚ : ¹èÀ翬
¿¬¶ôó : 02-3275-5335
À̸ÞÀÏ : kshf3@kshf.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í [»çÀüµî·Ï]±³¼ö, ºÀÁ÷ÀÇ, °³¿øÀÇ: 70,000¿ø / ÀüÀÓÀÇ,Á¦¾à °ü·Ã Á¾»çÀÚ: 30,000¿ø / Àü°øÀÇ, °£È£»ç, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ), ±ºÀÇ°ü: 10,000¿ø / 65¼¼ ÀÌ»ó, Çлý, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ): ¹«·á [ÇöÀåµî·Ï]±³¼ö, ºÀÁ÷ÀÇ, °³¿øÀÇ: 80,000¿ø / ÀüÀÓÀÇ,Á¦¾à °ü·Ã Á¾»çÀÚ: 40,000¿ø / Àü°øÀÇ, °£È£»ç, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ), ±ºÀÇ°ü: 20,000¿ø / 65¼¼ ÀÌ»ó, Çлý, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ): ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 10:20~10:35 Current Issues of Heart Failure in Korea - What's New from KorHFIII Registry? Á¶ÇöÀç(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 10:35~10:50 HF Epidemiology in Asia-Pacific Region Compared to Other Regions Jing Yu(Lanzhou University Second Hospital)
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 10:50~11:05 Considerations for the Diagnosis of HF in the Asia-Pacific Region - Present and Future Yasuhiko Sakata(National Cerebral and Cardiovascular Center)
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 11:05~11:20 Considerations for the Treatment of HF in the Asia-Pacific Region - Present and Future Nancy K. Sweitzer(Washington University School of Medicine)
Åä·Ð 09¿ù 21ÀÏ ±×·£µåº¼·ë 11:20~11:40 Discussion ±è¼Ò¸® ±èÀÎö ¼ÕÁ¤¿ì ÃÖÁø¿À(°í·ÁÀÇ´ë °è¸íÀÇ´ë ¿¬¼¼¿øÁÖÀÇ´ë ¼º±Õ°üÀÇ´ë)
½Ä»ç 09¿ù 21ÀÏ ±×·£µåº¼·ë 11:40~12:40 Lunch ( )
±âŸ 09¿ù 21ÀÏ ±×·£µåº¼·ë 12:40~13:00 Opening Ceremony ( )
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 13:00~13:15 Biomarker-driven prognostic models in chronic HFpEF Andrew Coats(Heart Research Institute)
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 13:15~13:30 The role and limitations of natriuretic peptides in contemporary landmark trials À¯º´¼ö(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 13:30~13:45 The different pathophysiology between HFrEF and HFpEF ±è´Ù·¡(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 13:45~14:00 The role of long non-coding RNAs detecting myocardial fibrosis ¿ÀÀç¿ø(¿¬¼¼ÀÇ´ë)
Åä·Ð 09¿ù 21ÀÏ ±×·£µåº¼·ë 14:00~14:20 Discussion Á¶µ¿Çõ ¹ÚÈÆÁØ È²¼®Àç(°í·ÁÀÇ´ë °¡Å縯ÀÇ´ë °æ»óÀÇ´ë)
ÈÞ½Ä 09¿ù 21ÀÏ ±×·£µåº¼·ë 14:20~14:40 Break ( )
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 14:40~14:55 HCM_diagnosis and risk stratification ÃÖÀÇ¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 14:55~15:10 HCM_current treatment strategy and future perspectives Yuya Matsue(Juntendo Univ.)
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 15:10~15:25 HCM_surgical treatment Á¤¼ºÈ£(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 15:25~15:40 Genetics in HCM ±è°æÈñ(ÀÎõ¼¼Á¾º´¿ø)
Åä·Ð 09¿ù 21ÀÏ ±×·£µåº¼·ë 15:40~16:00 Discussion ÃÖÀÚ¿¬ ¹Ú¿¹¹Î ÀÌÇöÁ¤ Á¤Çý¹®(°í·ÁÀÇ´ë °¡ÃµÀÇ´ë ¿¬¼¼ÀÇ´ë °æÈñÀÇ´ë)
ÈÞ½Ä 09¿ù 21ÀÏ ±×·£µåº¼·ë 16:00~16:30 Break ( )
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 16:30~17:00 Key inflammatory mechanisms and IL-6 in Heart Failure Adriaan A. Voors(University Medical Center Groningen)
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 17:00~17:15 Review of trials of anti-inflammatory treatment in Heart Failure ±è¹Î¼®(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09¿ù 21ÀÏ ±×·£µåº¼·ë 17:15~17:30 Sarcoidosis: Focus on antiInflammatory management Yuya Matsue(Juntendo Univ.)
Åä·Ð 09¿ù 21ÀÏ ±×·£µåº¼·ë 17:30~17:50 Discussion ÀÌÁøÈ ±èÀÎö ÀÌÂùÁÖ Á¶À翵(ÇѸ²ÀÇ´ë °è¸íÀÇ´ë ¿¬¼¼ÀÇ´ë Àü³²ÀÇ´ë)